ClinicalTrials.gg
Not yet recruitingNCT07487857CAMPUSENSUpdated Mar 23, 2026

Intensive Somatosensory Camp for Manual Function and Participation in Children With Unilateral Cerebral Palsy

An interventional study of Somatosensory-Motor Intensive Camp and Motor-Only Intensive Camp in Cerebral Palsy, sponsored by University of Castilla-La Mancha. Not yet recruiting. Open to participants aged 5 Years to 15 Years. Per ClinicalTrials.gov, last updated 2026-03-23.

Sponsored by University of Castilla-La Mancha · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
5 Years to 15 Years
Sex
All
01

Study summary

This study will evaluate whether an intensive day camp that combines somatosensory and motor training for the affected upper limb improves hand function and participation in children with unilateral cerebral palsy more than an intensive motor-only camp of equal duration and intensity. Children aged 5 to 15 years with unilateral spastic cerebral palsy and Manual Ability Classification System (MACS) levels I-III will be randomly assigned to one of two intervention groups. The experimental group will receive an 8-day, 40-hour camp including structured tactile, proprioceptive and vestibular stimulation integrated into meaningful functional tasks for the upper limb. The control group will receive an 8-day, 40-hour camp focused exclusively on intensive motor training without specific somatosensory stimulation.

The primary outcome is the change in spontaneous bimanual performance of the affected hand, measured with the Assisting Hand Assessment (AHA). Secondary outcomes include measures of unilateral upper limb function, somatosensory function, hand grip strength, gross motor function, balance, trunk control, participation in daily activities and objective upper limb activity measured with wrist-worn accelerometers. Outcomes will be assessed at baseline, immediately after the intervention, and at follow-up visits approximately 2 and 3 months after the camp.

Read the detailed description

Unilateral cerebral palsy is a common cause of motor disability in childhood and is frequently associated with somatosensory impairments of the affected upper limb, such as reduced tactile discrimination, impaired proprioception and difficulties with object recognition by touch. These sensory deficits contribute to learned non-use of the affected hand and limited spontaneous bimanual performance in daily activities, even when basic motor abilities are present. Intensive upper limb therapies, such as constraint-induced movement therapy and bimanual training, have shown positive effects on hand function, but most programs focus primarily on motor components and do not systematically target somatosensory function.

This randomized, controlled, single-blind clinical trial will compare two parallel intensive day-camp interventions for children with unilateral spastic cerebral palsy. Both groups will receive 40 hours of therapy over 8 consecutive days (5 hours per day) in a group-based camp format. The experimental group will participate in a structured somatosensory-motor program that integrates tactile, proprioceptive and vestibular stimulation within play-based, goal-oriented upper limb activities and functional workshops. Daily sessions include sensory activation (e.g., tactile massage, exploration of different textures), intensive tactile discrimination and haptic tasks (e.g., object recognition without vision, graded textures, vibration), and integration of somatosensory input into functional tasks and postural control activities (e.g., balance exercises on unstable surfaces, tasks with light weights).

The control group will receive an intensive motor-focused camp with the same total dose, schedule and therapist supervision. Activities will target active range of motion, strength, coordination, and functional use of the affected upper limb through standard manual tasks (such as reaching, grasping, building with blocks, threading, and fine motor games) and gross motor upper limb exercises and circuits, without structured somatosensory stimulation.

The primary objective is to determine whether the somatosensory-motor camp produces greater improvements in spontaneous bimanual performance of the affected hand, assessed by the Assisting Hand Assessment (AHA), compared with the motor-only camp. Secondary objectives include examining changes in unilateral upper limb movement quality (e.g., Melbourne Assessment of Unilateral Upper Limb Function), detailed somatosensory function (e.g., standardized assessments of tactile perception, two-point discrimination, proprioception and stereognosis), grip strength, gross motor function and balance, trunk control, participation and goal attainment, as well as objective upper limb activity recorded by wrist accelerometry in and outside the camp setting. Assessments will be conducted at baseline (T0), immediately after the intervention (T1, after 8 days) and at follow-up visits approximately 2 and 3 months after the camp.

The study is designed as a minimal-risk pediatric rehabilitation trial and follows ethical and data protection regulations. Randomization will be centralized, and outcome assessors and data analysts will be blinded to group allocation.

02

Conditions studied

  • Cerebral Palsy

Keywords

  • unilateral cerebral palsy
  • hemiparesis
  • upper limb function
  • somatosensory training
  • intensive rehabilitation
  • bimanual performance
  • pediatric
  • rehabilitation
03

In context

Cerebral Palsy

1,936 studies on the registry are indexed under Cerebral Palsy; 458 are open to participants now.

This study's planned enrollment of 26 is below the median of 34 across 1,431 interventional studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

University of Castilla-La Mancha is the lead sponsor of 107 studies on the registry; 26 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • diagnosis of spastic CP
  • aged between 5 and 15 years of age
  • able to follow simple verbal instructions and complete all the necessary tests according to their ages
  • MACS level I-III

Exclusion criteria

Exclusion Criteria:

  • uncontrolled epilepsy episodes in the 6 months prior to the start of the study
  • botulinum toxin in the last 6 months
  • orthopedic or neurological surgery in the 12 months prior to the start of the study or scheduled during the intervention development period
  • visual or cognitive disabilities that interfere with treatment
  • unable to actively participate in the activities
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
26 participants (estimated)

Study arms

  • Experimental
    Experimental: Somatosensory-Motor Intensive Camp

    8-day intensive day camp (40 hours total, 5 hours/day) for children with unilateral cerebral palsy. Combines structured somatosensory training (tactile discrimination, texture exploration, vibration stimulation, proprioception, vestibular input) integrated within functional upper limb motor tasks, play-based workshops, and balance activities targeting bimanual hand function and participation.

    Behavioral: Motor-Only Intensive Camp

  • Active comparator
    Active Comparator: Motor Camp

    8-day intensive day camp (40 hours total, 5 hours/day) focused exclusively on upper limb motor training for children with unilateral cerebral palsy. Includes active range of motion exercises, strength training, coordination circuits, grasping/manipulation tasks, and fine motor activities without structured somatosensory stimulation

    Behavioral: Somatosensory-Motor Intensive Camp

Interventions

  • BehavioralSomatosensory-Motor Intensive Camp

    Structured 8-day intensive rehabilitation camp (40 hours total, 5 hours/day) for children with unilateral cerebral palsy. Integrates somatosensory stimulation (tactile massage, texture discrimination, vibration therapy, proprioceptive exercises, vestibular/balance activities) within functional upper limb motor tasks, play-based workshops, and bimanual activities targeting spontaneous hand use and participation in daily activities.

  • BehavioralMotor-Only Intensive Camp

    Structured 8-day intensive rehabilitation camp (40 hours total, 5 hours/day) focused exclusively on upper limb motor training for children with unilateral cerebral palsy. Includes active range of motion exercises, grip strength training, fine motor coordination tasks (grasping, threading, block manipulation), reaching/coordination circuits without structured somatosensory stimulation.

06

What researchers measure

Primary outcomes

  1. Assisting Hand Assessment (AHA)

    Change in spontaneous bimanual hand use of the affected upper limb in children with unilateral cerebral palsy, measured by the Assisting Hand Assessment (AHA). The AHA is a video-based, criterion-referenced measure of how effectively a child with a unilateral hand impairment spontaneously uses their affected hand during bimanual play activities. Scores range from 0-100 (higher scores indicate better bimanual performance).

    Time frame: Baseline (T0), immediately after intervention (T1, 8 days), follow-up at 1 month (T2)

Secondary outcomes

  1. Melbourne Assessment of Unilateral Upper Limb Function Version 2 (MA-2)

    Quality of unilateral upper limb movement (range of motion, accuracy, dexterity, fluency) in children with unilateral cerebral palsy, measured by video analysis using MA-2 standardized criteria.

    Time frame: Baseline (T0), immediately after intervention (T1, 8 days), follow-up at 1 month (T2)

  2. Somatosensory Function (SWM, 2PD, Stereognosis)

    Tactile discrimination and somatosensory function of the affected hand measured by Semmes-Weinstein Monofilaments (SWM) for touch threshold, two-point discrimination (static/dynamic), localization, double simultaneous stimulation, and stereognosis (object recognition by touch).

    Time frame: Baseline (T0), immediately after intervention (T1, 8 days), follow-up at one month (T2)

  3. Hand Grip Strength (Jamar Dynamometer)

    Maximum cylindrical grip strength (kg) of affected and non-affected hands, measured in standardized sitting position with 3 trials per hand using Jamar hydraulic dynamometer.

    Time frame: Baseline (T0), immediately after intervention (T1, 8 days), follow-up at one month (T2)

  4. Upper Limb Activity (Wrist Accelerometry)

    Objective measurement of spontaneous upper limb movement quantity and intensity using wrist-worn accelerometers on both wrists during AHA assessment and daily life outside camp.

    Time frame: Baseline (T0), during daily life in camps days, immediately after intervention (T1, 8 days), follow-up at one month (T2)

  5. Participation (COPM, PEM-CY)

    Family-identified functional priorities and participation in daily activities measured by Canadian Occupational Performance Measure (COPM) performance/satisfaction scores and Participation Environmental Measure-Children and Youth (PEM-CY) frequency/involvement dimensions in school, home and community.

    Time frame: Baseline (T0), immediately after intervention (T1, 8 days), follow-up at 1 month (T2)

  6. GMFM-66 (Gross Motor Function Measure-66 Item Set)

    It is a validated observational instrument that assesses changes in gross motor function in children with cerebral palsy from 5 months to 16 years of age. It consists of 66 items grouped into five dimensions (supine/rolled over, sitting, crawling/kneeling, standing/walking). Scoring is expressed as a percentage (0-100). The Item Set groups the items according to age and the corresponding GMFCS level, thus shortening the assessment and eliminating the need to examine all 66 items of the original GMFM-66. The score is then calculated using the GMAE software.

    Time frame: Baseline (T0), immediately after intervention (T1, 8 days), follow-up at 1 month (T2)

  7. Pediatric Balance Scale (PBS)

    This is a modified version of the Berg Balance Scale for school-aged children (4-15 years) with mild-to-moderate motor disabilities. It assesses 14 functional static/dynamic balance tasks (sitting, standing, reaching, turning). Each item is scored from 0-4 (maximum total 56). It will be used up to age 8 in this study.

    Time frame: Baseline (T0), immediately after intervention (T1, 8 days), follow-up at 1 month (T2)

  8. Trunk Control Measurement Scale (TCMS-S)

    It is used to measure trunk control during functional activities in a seated position. It provides a structured and quantitative assessment of how a person controls their trunk both statically and in motion, including balance, selective trunk movements, and dynamic reach beyond the base of support. It is validated for individuals with neuromotor impairment aged 5 to 19 years.

    Time frame: Baseline (T0), immediately after intervention (T1, 8 days), follow-up at 1 month (T2)

  9. Children's Hand-use Experience Questionnaire (CHEQ

    This is an online questionnaire completed by parents and/or the child that assesses the perception of hand use during different bimanual activities. It has two versions: the mini-CHEQ for children aged 3-8 years and the CHEQ for children aged 6-18 years. The questionnaire is completed by parents for children under 13 years of age. For children over 13 years of age, both parents and children complete it. It takes 20-30 minutes to complete.

    Time frame: Baseline (T0), immediately after intervention (T1, 8 days)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — No IPD sharing planned. This minimal-risk pediatric rehabilitation trial involves children with unilateral cerebral palsy (ages 5-15) and includes sensitive clinical data such as video assessments (AHA, MA-2), detailed somatosensory testing, actigraphy, and family-reported functional priorities (COPM). Data cannot be sufficiently de-identified while preserving scientific utility due to the small sample size (n=26) and specialized outcome measures. Aggregate results will be published following CONSORT guidelines.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2026; primary completion for Oct 2026, 4 months later.

Of 902 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 4 months is below that.

Counting every sponsor, half of 921 studies reached it within 12 months; a quarter within 5 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 17, 2026
First posted
Mar 23, 2026
StartEst.
Jun 20, 2026
Primary completionEst.
Oct 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Mar 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07487857
Responsible party
Sponsor
First posted
Mar 23, 2026
Start date
Jun 20, 2026 (estimated)
Primary completion
Oct 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Mar 23, 2026

Study contacts

Rocío Palomo Carrión PhD
Contact
rocio.palomo@uclm.es
926051821 ext. +34

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion